Qing Liu

US Patent:

20060121471, Jun 8, 2006

Filed:

Aug 14, 2003

Appl. No.:

10/524258

Inventors:

Sang-Seok Koh - Taejeon, KR
Hyun-Ho Chung - Taejeon, KR
Bog-Man Lee - Taejeon, KR
Si-Young Song - Taejeon, KR
Qing Liu - Gaithersburg MD, US
Wen Zeng - Gaitherburg MD, US

Assignee:

L G Life Sciences ltd. - Seoul

International Classification:

C12Q 1/68
G01N 33/574
C07H 21/04
C12P 21/06
C07K 14/82
C07K 16/30

US Classification:

435006000, 435007230, 435069100, 435320100, 435325000, 530350000, 530388800, 536023500

Abstract:

The invention relates generally to the changes in gene expression in stomach cancer. The invention relates specifically to human gene families that correspond to mRNA species that are differentially expressed in cancerous stomach tissue compared to normal stomach tissue.

US Patent:

20060183186, Aug 17, 2006

Filed:

Dec 20, 2002

Appl. No.:

10/499698

Inventors:

Sang Koh - Daejeon, KR
Qing Liu - Gaithersburg MD, US
Hyun-Ho Chung - San Diego CA, US
Wen Zeng - Gaithersburg MD, US
Bogman Lee - Daejeon, KR
Subrahmanyam Yeramilli - Clarksville MD, US
Si Song - Madu, KR

International Classification:

C12P 21/06

US Classification:

435069100

Abstract:

The present invention results from the examination of tissue from stomach tumors to identify genes that are differentially expressed between cancerous and normal tissue. The invention includes diagnostic, monitoring, drug design and therapeutic methods using these genes, as well as solid supports comprising oligonucleotide arrays that are complementary to or hybridize to the differentially expressed genes.

US Patent:

20080050719, Feb 28, 2008

Filed:

Dec 20, 2002

Appl. No.:

10/499695

Inventors:

Sang Seok Koh - Daejeon, KR
Qing Liu - Gaithersburg MD, US
Hyun-Ho Chung - Gaithersburg MD, US
Weu Zeng - Gaithersburg MD, US
Bogman Lee - Daejeon, KR
Subrahmanyam Yeramilli - Gaithersburg MD, US
Si Young Song - Daejeons, KR

International Classification:

C12Q 1/68
G01N 33/574
A61K 38/17
A61K 48/00
G06F 19/00
C12M 1/34

US Classification:

435 6, 435 723, 4352872, 702 20, 514 12, 514 44, 977924

Abstract:

The present invention results from the examination of tissue from hepatic carcinomas to identify genes differentially expressed between cancerous liver tissue and diseased but non-cancerous liver tissue. The invention includes diagnostic, screening, drug design and therapeutic methods using these genes, as well as solid supports comprising oligonucleotide arrays that are complementary to or hybridize to the differentially expressed genes.

US Patent:

20080087725, Apr 17, 2008

Filed:

Oct 11, 2006

Appl. No.:

11/548372

Inventors:

Qing Liu - Arlington VA, US

International Classification:

G06F 19/00

US Classification:

235385

Abstract:

An item locator system including a computer responsive to the commands of a user of the computer corresponding to a location of a plurality of items within an establishment, the establishment including a plurality of display fixtures identifiable using identification codes, the computer having access to stored data comprising information regarding the location of the plurality of items within the establishment, the computer upon receiving a request from the user displays the identification codes of the display fixtures where the plurality of items can be found.

US Patent:

20110174228, Jul 21, 2011

Filed:

Jan 21, 2011

Appl. No.:

13/011474

Inventors:

Qing LIU - Vienna VA, US

International Classification:

B01D 15/00
A01K 29/00

US Classification:

119173

Abstract:

A hybrid litter for pets and a method of making a hybrid litter for pets is provided. The litter includes a hybrid composition of inorganic clay, silica gel, and biodegradable materials, such as corn, wheat, alfalfa, peanut hulls, ground walnut shells, sawdust, and mixtures thereof and a low density mineral, such as perlite, diatomaceous earth, or pumice.

US Patent:

20220212048, Jul 7, 2022

Filed:

Mar 28, 2022

Appl. No.:

17/705711

Inventors:

- Wilson NC, US
Terry Simpson - Wake Forest NC, US
Mark P. Fazzio - Wilson NC, US
Eli Baldwin - Knightdale NC, US
Marios C. Soteriou - Middletown CT, US
Paul Papas - West Hartford CT, US
Qing Liu - Wake Forest NC, US

International Classification:

A62D 1/00

Abstract:

A fire suppression composition comprises CFI and CO, wherein said CFI is present in an amount of from 23 mol. % to 39 mol. %, based on the total moles of CFI and COpresent in the fire suppression composition. Alternatively, the fire suppression composition comprises CFI and CO, wherein said CFI is present in an amount of from 53 mol. % to 85 mol. %, based on the total moles of CFI and COpresent in the fire suppression composition.

US Patent:

20230088487, Mar 23, 2023

Filed:

Feb 16, 2021

Appl. No.:

17/798744

Inventors:

- Wilson NC, US
Terry Simpson - Wake Forest NC, US
Mark P. Fazzio - Wilson NC, US
Harlan Hagge - Knightdale NC, US
Paul Papas - West Hartford CT, US
Marios C. Soteriou - Middletown CT, US
Eli Baldwin - Knightdale NC, US
Qing Edda Liu - Wake Forest NC, US

International Classification:

A62D 1/00
C07C 19/16
C07C 19/14

Abstract:

A fire suppression blends of CF3I and 2-BTP with mol ratios from 1:5 and 5:1 are capable of passing peak inerting and sub-inerting tests. The CF3I: 2-BTP fire suppression blends can also include carbon dioxide of up to 80% of the fire suppression blend to provide additional cooling.

US Patent:

20230066103, Mar 2, 2023

Filed:

Feb 16, 2021

Appl. No.:

17/798751

Inventors:

- Wilson NC, US
Terry Simpson - Wake Forest NC, US
Harlan Hagge - Knightdale NC, US
Mark P. Fazzio - Wilson NC, US
Marios C. Soteriou - Middletown CT, US
Paul Papas - West Hartford CT, US
Eli Baldwin - Knightdale NC, US
Qing Edda Liu - Wake Forest NC, US

International Classification:

A62D 1/00

Abstract:

A fire suppressant blend comprises CF3I; at least one hydrofluoro-olefin (HFO) or hydrochlorofluoro-olefin (HCFO), or both; and carbon dioxide.